Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REGENECYTE for Fatigue in Post-COVID Condition
NCT07184385Phase 3Not yet recruiting
- Sponsor
- StemCyte Inc.
- Start
- Mar 2026
- Primary completion
- Jun 2027
- Modality
- Stem Cell Therapies
01
Overview
A Phase 3 trial of RegeneCyte in post-COVID-19 condition (PCC), sponsored by StemCyte Inc.. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
RegeneCyte
03
Conditions
post-COVID-19 condition (PCC)
Beyond the preview
Go deeper on NCT07184385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07184385.